论文部分内容阅读
目的探讨米索前列醇和缩宫素联合应用在预防产后出血中的临床价值。方法 95例分娩的产妇,按随机数字表法将其分为对照组(47例)和观察组(48例)。对照组产妇分娩后给予肌内注射20 U缩宫素,观察组在对照组基础上给予0.4 mg米索前列醇肛塞,观察两组产妇术后2、24 h出血量,同时记录两组产妇不良反应发生情况。结果观察组产妇术后2、24 h出血量均明显少于对照组,差异具有统计学意义(P<0.05);两组产妇不良反应发生率对比差异无统计学意义(P>0.05)。结论米索前列醇和缩宫素联合应用在预防产后出血中效果显著,不良反应少,临床推广价值较高。
Objective To investigate the clinical value of combination of misoprostol and oxytocin in the prevention of postpartum hemorrhage. Methods A total of 95 pregnant women giving birth were divided into control group (n = 47) and observation group (n = 48) by random number table method. In the control group, the intrauterine injection of 20 U oxytocin was given to the pregnant women after giving birth. The observation group was given 0.4 mg misoprostol on the basis of the control group. The bleeding volume at 2 and 24 hours after the operation was observed. Adverse reactions occurred. Results The bleeding volume of the observation group was significantly lower than that of the control group at 2 and 24 hours after operation (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion The combination of misoprostol and oxytocin is effective in preventing postpartum hemorrhage with less adverse reactions and higher clinical popularization value.